Grail, a biotech company with early backing from Microsoft co-founder Bill Gates and Amazon founder Jeff Bezos, says it’s raised $300 million in an oversubscribed Series C financing round. Gates and Bezos got in on a $100 million Series A round in 2016, and since then, total investment has risen to $1.5 billion.
